The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors-Reference-Cited by-同舟云学术

The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors

Published:2017-10-04 Issue:2 Volume:142 Page:381-391
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

de Gooijer Mark C.¹²^ORCID,Zhang Ping¹²³,Weijer Ruud¹²,Buil Levi C.M.¹²,Beijnen Jos H.¹⁴⁵,van Tellingen Olaf¹²^ORCID

Affiliation:

1. Division of Pharmacology; The Netherlands Cancer Institute, Plesmanlaan 121; Amsterdam 1066 CX The Netherlands

2. Mouse Cancer Clinic, The Netherlands Cancer Institute, Plesmanlaan 121; Amsterdam 1066 CX The Netherlands

3. Department of Neurosurgery; Qilu Hospital, Shandong University, Wenhua Xi Road 107; Jinan 250012 People's Republic of China

4. Department of Pharmacy and Pharmacology; The Netherlands Cancer Institute/MC Slotervaart Hospital, Louwesweg 6; Amsterdam 1066 EC The Netherlands

5. Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science; Utrecht University, Universiteitsweg 99; Utrecht 3584 CG The Netherlands

Funder

StopHersentumoren.nl

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013

2. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;The Cancer Genome Atlas Research Network;N Engl J Med.,2015

3. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma;Wu;Nat Genet.,2014

4. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma;Bender;Nat Med.,2016

5. Genomic classification of cutaneous melanoma;Cancer Genome Atlas N;Cell,2015

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in antitumour therapy with oncolytic herpes simplex virus combinations;Discover Oncology;2024-07-24

2. Druggable genomic landscapes of high-grade gliomas;Frontiers in Medicine;2023-12-08

3. Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma;Molecular Therapy - Methods & Clinical Development;2023-12

4. New era of nanoparticles facilitated co-delivery in cancer therapy: two heads are better than one;Journal of Nanoparticle Research;2023-09

5. Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion;Scientific Reports;2023-06-06